Analysis of 200 patients: Clinical manifestations and aetiology of Recurrent Corneal Erosion Syndrome
DOI:
https://doi.org/10.51168/sjhrafrica.v5i9.1383Keywords:
corneal erosion, meibomian gland dysfunction, recurrent corneal erosion syndrome, photorefractive keratectomy, epithelial basement membrane dystrophyAbstract
Objective: To investigate the clinical characteristics and causes of recurrent corneal erosion syndrome (RCES).
Methods: We conducted a study on 200 patients (185 eyes) diagnosed with Recurrent Corneal Erosion Syndrome (RCES) at our institution, Netaji Subhas Medical College and Hospital, Bihta, Patna. The analyzed data encompassed information on demographics, causes, position on the cornea, and the relationship with meibomian gland dysfunction (MGD).
Findings: The average age of participants was 44.5 years, with a range of 14-80 years. The identified causes of Recurrent Corneal Erosion Syndrome (RCES) were as follows: prior minor trauma (73 eyes, 39.45%), photorefractive keratectomy (31 eyes, 16.75%), epithelial basement membrane corneal dystrophy( EBMD) (31 eyes, 16.75%), laser-assisted in situ keratomileusis (14 eyes, 7.56%), and unknown origin (36 eyes, 18.91%). The inferior paracentral cornea was the most common area for recurrent corneal erosions (RCES), accounting for 68.4% of cases. The upper cornea and other locations were less frequently affected, with each accounting for 21.3% of cases. MGD was present in 59% of patients.
Summary: Recurrent corneal erosion syndrome (RCES) can be caused by many factors, which account for the diverse range of symptoms observed in individuals with the condition. Notably, a considerable proportion of patients with Recurrent Corneal Erosion disease (RCES) start experiencing the disease after undergoing keratorefractive surgery, a significant proportion of individuals also exhibit Meibomian Gland Dysfunction (MGD).
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Niharika Singh, Arjun Kumar Singh
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.